Acorda Therapeutics Stock Price. Everything You Need To Know About The Acorda Therapeutics Stock! Acorda Therapeutics Stock Price. Everything You Need To Know About The Acorda Therapeutics Stock!


Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. The company is headquartered in Pearl River, New York and currently employs 111 full-time employees. The company went IPO on 2006-02-10. The firm is focused on developing therapies that restore function and enhance the lives of people with neurological disorders. The firm uses its ARCUS pulmonary delivery system, which is a technology platform designed to deliver medication through inhalation that is used in the development of a variety of inhaled medicines. The Company’s commercial products include INBRIJA (levodopa inhalation powder) and AMPYRA (dalfampridine). Inbrija is an inhaled levodopa (L-dopa) for intermittent treatment of OFF episodes, also known as OFF periods in people with Parkinson’s disease treated with carbidopa/levodopa regimen. Inbrija utilizes its ARCUS platform for inhaled therapeutics. AMPYRA (dalfampridine) is an extended-release tablet formulation of dalfampridine as a treatment to enhance walking in patients with multiple sclerosis (MS). Ampyra is marketed as Fampyra outside the United States by Biogen International GmbH.



Acorda Therapeutics Stock Price. Everything You Need To Know About The Acorda Therapeutics Stock! performance

  • Employees 111
  • Company HQ Pearl River
  • Website http://www.acorda.com/
  • Asset Type
  • Market Capitalization 0
  • Earnings Per Share
  • Dividends Per Share
  • Dividend Date
  • Quarterly Earnings Growth

Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the stock of Acorda Therapeutics? Look no further! At Zorion, our investment platform provides you with the resources and insights you need to make informed investment decisions. Acorda Therapeutics is a leading biopharmaceutical company focused on developing therapies to improve the lives of people with neurological disorders. To invest in Acorda Therapeutics from Malaysia, Thailand, Indonesia, and Vietnam, follow these steps: 1) Open an account with Zorion, 2) Complete the necessary verification process, 3) Add funds to your account, and 4) Search for Acorda Therapeutics and place your investment order. Stay ahead of the investment curve with Zorion! Start investing today.


Want To Buy Acorda Therapeutics Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: